Retrophin, Inc.

Net Promoter Score 2019 Benchmarks

Estimated Net Promoter Score is

7

Martin Shkreli of the biotechnology firm Retrophin, and founder and former CEO of Turing Pharmaceuticals.

In September 2015, Shkreli received widespread criticism when Turing obtained the manufacturing license for the antiparasitic drug Daraprim and raised its price by a factor of 56, leading him to be referred to by media as "the most hated man in America" and "pharma bro".

In December 2015, Shkreli was arrested by the FBI after being indicted on federal charges of securities fraud. He is free on bail pending trial. He resigned as CEO of Turing Pharmaceuticals and was replaced by the company's board chairman, Ron Tilles.

In January 2016, Fortune estimated the then 32-year-old Shkreli's net worth as at least US $45,000,000 but later updated its profile to reflect that "ince this article was published the value of Shkreli's E*Trade account has dropped by more than $40 million". Shkreli leveraged a US $4,000,000 E-Trade account for his bail.

Net Promoter Score for Top Brands compared with Retrophin, Inc.

What is Net Promoter Score?

NPS is a customer loyalty metric that measures customers’ willingness to not only return for another purchase or service but also make a recommendation to their family, friends or colleagues.

It is a powerful and effective technique, which can greatly increase a company's revenue if used properly.

The main advantages of NPS are close correlation with a company's growth and easy collection, interpretation and communication of the data.